Literature DB >> 2500373

Effects of puberty on seizure frequency.

S Niijima1, S J Wallace.   

Abstract

Seizure frequency was documented before, during and in some cases after puberty for 12 patients with continuing generalised tonic-clonic seizures (GTCS) and for 14 with complex partial seizures (CPS) who were receiving anti-epileptic drugs. For the patients with GTCS there was a significant increase in seizure frequency during the pubertal growth-spurt, with a subsequent decrease after growth ceased. There appeared to be no relationship between puberty and the frequency of CPS. Both groups were more likely to have suboptimal plasma drug-levels during puberty, suggesting that medication was not the cause of the increased GTCS frequency. Further examination of hormonal levels in relation to frequency of GTCS during puberty could provide a better understanding of the influence of hormones.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500373     DOI: 10.1111/j.1469-8749.1989.tb03976.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  5 in total

1.  The treatment of epilepsy in autism.

Authors:  C Gillberg
Journal:  J Autism Dev Disord       Date:  1991-03

Review 2.  Neurosteroids and their role in sex-specific epilepsies.

Authors:  Doodipala Samba Reddy
Journal:  Neurobiol Dis       Date:  2014-06-21       Impact factor: 5.996

Review 3.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

Review 4.  Neuroendocrine aspects of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Horm Behav       Date:  2012-05-02       Impact factor: 3.587

5.  Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial.

Authors:  Ellen N Hurley; Carolyn J Ellaway; Alexandra M Johnson; Linda Truong; Rebecca Gordon; Peter Galettis; Jennifer H Martin; John A Lawson
Journal:  Epilepsia       Date:  2022-04-20       Impact factor: 6.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.